IPO
Meituan-Dianping gains on debut after $4.2b Hong Kong IPO
Chinese online-to-offline (O2O) lifestyle services platform Meituan-Dianping gained 5.3% on its trading debut in Hong Kong following a HK$33.1 billion ($4.2 billion) IPO.
China technology: Burnout
Questions about the sustainability of Meituan-Dianping's expansion strategy suggest that even newly listed unicorns are not immune to the changing sentiment in China's technology sector
PE-backed WuXi AppTec targets Hong Kong listing
Wuxi AppTec, a contract pharmaceutical R&D services provider backed by several private equity investors, has filed for a Hong Kong listing less than four months after listing in Shanghai. The size and pricing of the IPO have yet to be decided, but the...
Renminbi fundraising: Winter has come
A two-year renminbi fundraising boom in China has ended abruptly due to a combination of controversy, regulatory intervention, and dwindling investor sentiment. But the market may benefit in the long term
China's Qutoutiao soars on debut after $84m US IPO
Chinese news aggregator app Qutoutiao raised $84 million in a downsized US IPO – continuing a recent trend among Chinese tech start-ups – but then saw its stock price more than double on the first day of trading.
China Renaissance set for wealth management push
China Renaissance Holdings is planning an aggressive push into wealth management services, targeting high net worth individuals in China’s new economy, with proceeds from its upcoming Hong Kong IPO.
PE-backed Chinese online pharmacy completes $100m US IPO
Chinese online pharmacy operator 111 Inc – best known for its 1 Drugsstore platform – traded down slightly on its NASDAQ debut after raising $100.5 million in a scaled back IPO.
China's Nio trades up after smaller-than-expected US IPO
Chinese electric vehicle (EV) maker Nio – which claims its premium vehicle is cheaper and better quality than the Tesla Model X – ended its first day of trading in New York 5.4% above the IPO price following a $1 billion offering.
IFC-backed Angel Broking files for India IPO
Indian financial services provider Angel Broking has filed for an IPO that will raise up to INR6 billion ($83 million) and provide a partial exit to the International Finance Corporation (IFC).
Meituan-Dianping targets $4.4b IPO, promises domestic focus
Meituan-Dianping, China’s leading online-to-offline (O2O) lifestyle services platform, is looking to raise up to HK$34.6 billion ($4.4 billion) in its Hong Kong IPO, while emphasizing that it will focus on its core domestic business rather than pushing...
Orchid, TPG-backed Duiba files for Hong Kong IPO
Duiba, a Chinese enterprise services company in which Orchid Asia and TPG Capital recently invested $110 million, has filed for a Hong Kong listing.
L Catterton-owned menswear brand targets HK listing
China-based fashion menswear retailer GXG, in which consumer-focused GP L Catterton Asia and Crescent Point hold a controlling stake, has filed for an IPO in Hong Kong.
China language learning app Liulishuo files for US IPO
Liulishuo, a Chinese English language learning app that uses artificial intelligence (AI) to deliver customized teaching solutions for adults, has filed to list in the US.
Chinese IoT platform Viomi files for US IPO
Viomi, a Chinese manufacturer of smart household devices that works in partnership with smart phone maker Xiaomi and counts Shunwei Capital and Sequoia Capital China as investors, has filed for an IPO in the US.
China’s PE-backed Tubatu files for HK IPO
Tubatu, a Chinese online home renovation platform backed by Matrix Partners and Sequoia Capital, has filed for an IPO in Hong Kong.
Korean IPOs: The public eye
A growing number of South Korean buyout firms are testing the waters for domestic IPOs. Continued regulatory hurdles mean that realizing value will require planning for the post-offer period
SAIF-backed Senco files for $86m India IPO
Senco Gold, an Indian jewelry chain backed by SAIF Partners, has filed for an IPO, seeking to raise up to INR6 billion ($86 million).
China PE: Exit issues
Chinese GPs appear to be reevaluating their exit options as a shifting landscape for local IPO and trade sale markets suggests economic concerns and increased scrutiny
CDH-backed Mabpharm files for Hong Kong IPO
Mabpharm, a China-based biopharmaceutical company backed by CDH Investments, has filed for an IPO in Hong Kong, the latest in a growing number of proposed listings under new rules that allow biotech companies with no revenue or profits to go public.
JD.com-backed Farfetch to go public in US
UK-based luxury online fashion retailer Farfetch, which has received significant funding from Asian investors including China’s JD.com, has filed for a US IPO.
China’s Ascentage Pharma files for HK IPO
Ascentage Pharma, a Chinese biopharmaceutical company with several private equity backers, has filed for an IPO in Hong Kong.
Chinese news aggregator Qutoutiao preps for US offering
Qutoutiao, a Chinese news aggregator app that seeks to differentiate itself from market leader Jinri Toutiao by focusing on entertainment-oriented content, has announced plans to list in the US.
Qiming, Sequoia-backed CooTek files for US IPO
CooTek, a Chinese company that also goes by the name of Chubao and is best-known for the TouchPal smart phone keyboard, is seeking to go public in the US.
Rohatyn-backed Sansera files for India IPO
Indian automotive and aerospace parts manufacturer Sansera Engineering has filed for an IPO that will provide a partial exit for its private equity backer The Rohatyn Group (TRG).
